PORTLAND, Ore. & DENVER--(BUSINESS WIRE)--LGInternational (LGI), manufacturer of advanced labeling solutions, and Sharklet Technologies, Inc., developer of the Sharklet™ technology that inhibits bacterial survival and transfer through a surface micro-pattern, today announced a breakthrough business agreement through which LGI has licensed Sharklet-patterned films to create a new line of bacterial inhibition products targeted for use on high-touch surfaces in the healthcare market. LGI is bringing the bacterial inhibition covers to market via its Tactivex® product line.
